Company Filing History:
1 out of 2,202 
1 out of 1,217 
Years Active: 1997-1999
Title: Lee Pai: Innovator in Antibody Fusion Proteins
Introduction
Lee Pai is a distinguished inventor based in Silver Spring, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody fusion proteins. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Lee Pai's latest patents include innovations related to single chain B3 antibody fusion proteins. This invention provides recombinant single chain antibodies capable of specifically binding to a Lewis Y-related carbohydrate antigen and fusion proteins comprising these antibodies. More particularly, the invention focuses on single chain Fv regions of the monoclonal antibody B3. Additionally, it offers a method for improving the binding affinity of antibodies lacking a serine at position 95 of the VH region by mutating position 95 to a serine.
Career Highlights
Throughout his career, Lee Pai has worked with notable organizations, including the United States of America as represented by the Secretary of Health and the Department of Health. His expertise in antibody technology has positioned him as a key figure in the field.
Collaborations
Lee has collaborated with esteemed colleagues such as Ira H. Pastan and Mark C. Willingham. Their combined efforts have contributed to advancements in antibody research and development.
Conclusion
Lee Pai's innovative work in antibody fusion proteins showcases his commitment to advancing biotechnology. His patents and collaborations reflect a dedication to improving medical therapies and understanding antibody interactions.